Acne vulgaris is a prevalent dermatological condition that is often treated with isotretinoin, a potent medication effective in moderate to severe cases. However, its use requires careful monitoring because of its potential hepatotoxic effects. Isotretinoin has been associated with transient elevations in liver enzyme levels, with mild abnormalities observed in up to 11% of cases. Severe elevations (grade ≥ 3), indicating potential liver dysfunction, occur infrequently, with an incidence of approximately 0.2% to 0.5%. The mechanisms underlying isotretinoin-induced liver injury involve oxidative stress and genetic susceptibility, primarily manifesting as idiosyncratic drug-induced liver injury. Most enzyme abnormalities occur within the initial months of treatment, and their clinical significance varies, with many cases resolving without intervention. A review of large cohort studies highlighted the incidence of abnormal liver function tests, including elevated alanine aminotransferase and aspartate aminotransferase levels. These abnormalities are often present within the first 3 months of therapy, particularly at higher cumulative doses. The role of routine liver function monitoring is debated, with recommendations favoring baseline and early follow-up tests and further testing guided by clinical indicators. Alanine aminotransferase may serve as a more specific marker for liver injury compared to other markers, such as aspartate aminotransferase. This review highlights the importance of evidence-based guidelines to balance effective acne treatment with the risk of isotretinoin-induced hepatotoxicity. Standardizing monitoring protocols and integrating genetic and oxidative stress markers may enhance safety and therapeutic outcomes. Further research is essential to refine these strategies and address gaps in long-term hepatotoxicity data.

Background: The influence of digital media on public perception of sexual health is significant and relates to its effects on knowledge, attitudes, and behaviors. Motion graphics and animation represent a novel innovation in health-related communication. The visual attractiveness and adaptability to cultural issues offer an alternative means of conveying often sensitive issues. This systematic review aimed to provide an overview of their efficacy in delivering sexual health messages and to identify the components contributing to success. Methods: A literature search was conducted using Scopus, MEDLINE (via PubMed), and DOAJ, covering studies from inception to 31 August 2025. All eligible studies included randomized controlled trials, quasi-experimental studies, and other evaluations, which were synthesized by outcomes related to knowledge, attitudes, behaviors, intentions, and/or psychosocial well-being. The study was pre-registered on the INPLASY platform (INPLASY202580073). Results: Eleven studies published between the years 1989 and 2025 met the inclusion criteria. The majority reported improvements in sexual health knowledge and attitudes, and several studies also demonstrated improved behaviors and psychosocial well-being. Factors that contributed to interventions that have been successful were cultural adaptation, being based on theory, and presentation over time. Conclusions: Motion graphics and animation, therefore, represent an exciting means of sexual health promotion and stigma reduction. Future studies should therefore focus on the determination of standardized formats for media presentations, the evaluation of long-term effects, and the evaluation of cost–benefit to enhance the effectiveness of media communication in health promotion.

Background/Objectives: Facial melasma is a common, chronic, and relapsing hyperpigmentation disorder, affecting up to 40% of adult women in Southeast Asia. Although most cases are mild, the condition may have a considerable psychological impact. Ocular photoaging diseases are also common and have been increasingly recognized in aging populations exposed to chronic sunlight. Ultraviolet (UV) radiation is implicated in both melasma and ocular photoaging; however, their relationship remains unclear. Methods: This cross-sectional study investigated the association between facial melasma and UV-induced ocular conditions among 315 participants aged 30–80 years at Walailak University Hospital, Thailand. Facial melasma was diagnosed clinically and dermoscopically, with severity assessed using the modified Melasma Area Severity Index. Ophthalmological examinations evaluated UV-related ocular conditions, including pinguecula, pterygium, climatic droplet keratopathy, cataracts, and age-related macular degeneration. Logistic regression analyses were performed, adjusting for age, sex, and sun exposure. Results: Facial melasma was identified in 66.0% of participants (n = 208), and nuclear cataracts were significantly associated with melasma (adjusted odds ratio, 2.590; 95% confidence interval, 1.410–4.770; p = 0.002). Additionally, melasma severity correlated with nuclear cataract severity (ρ = 0.186, p = 0.001). Other ocular conditions were not significantly associated with melasma. Conclusions: These findings suggest a shared UV-related pathogenesis between facial melasma and nuclear cataracts. Sun protection measures, including regular sunscreen use, UV-blocking eyewear, and wide-brimmed hats, may help mitigate the risk of both conditions. Further multicenter studies are warranted to confirm these findings and explore the underlying mechanisms.

Background/Objectives: The objective of this scoping review was to systematically map the available evidence for the management of scleredema diabeticorum (SD) to summarize the documented clinical outcomes with the aim to inform clinical practice and identify research gaps. Methods: We conducted a scoping review identifying studies published in English from January 2005 to July 2025 through a comprehensive search of Scopus, MEDLINE, and the Cochrane Library. Eligible studies included randomized controlled trials, observational studies, case series, and case reports on treatment interventions and clinical outcomes. Two reviewers independently screened records, extracted data, and narratively and descriptively synthesized data. Results: Forty-five studies met the inclusion criteria: 39 single-patient case reports, five case series, and one multicenter observational study. The most common interventions were PUVA (8 studies, 14 patients; 12/14 improved, 85.7%), methotrexate (8 studies, 22 patients; 8/22 improved, 36.4%), and improved glycemic control (9 studies, 12 patients; mixed responses). Across small case reports/series, PUVA, UVA-1, and IVIG were most frequently reported as beneficial. Methotrexate monotherapy showed low and inconsistent effectiveness, with higher responses when combined with other agents. Other reported therapies included colchicine, electron-beam radiation, tranilast, and topical hyaluronidase. Conclusions: PUVA, UVA-1, and IVIG may offer benefit, while methotrexate alone is often ineffective. Evidence is predominantly from case reports and small series, which makes it difficult to generalize. Multicenter trials with standardized protocols are needed to develop evidence-based treatment recommendations.

INPLASY202570068 The Role of Game-Based Learning in Dermatology: A Scoping Review on Patient Education Keywords: Game-based learning; dermatology; patient education; gamification; serious games; au…

INPLASY202570063 Effectiveness of Game-Based Learning in Dermatology Patient Education: A Systematic Review Keywords: dermatology; patient education; game-based learning; gamification; serious game…